| Literature DB >> 31444364 |
Farman Ullah1, Hina Gul1, Hafiz Kamran Yousaf1, Wang Xiu1, Ding Qian1, Xiwu Gao1, Kaleem Tariq2, Peng Han3, Nicolas Desneux4, Dunlun Song5.
Abstract
Buprofezin, a chitin synthesis inhibitor that can be used for the control of hemipteran pests, especially melon aphid, Aphis gossypii. The impact of low lethal concentrations of buprofezin on the biological parameters and expression profile of CHS1 gene were estimated for two successive generations of A. gossypii. The present result shows that the LC15 and LC30 of buprofezin significantly decreased the fecundity and longevity of both generations. Exposure of F0 individuals to both concentrations delay the developmental period in F1. Furthermore, the survival rate, intrinsic rate of increase (r), finite rate of increase (λ), and net reproductive rate (R0) were reduced significantly in progeny generation at both concentrations. However, the reduction in gross reproductive rate (GRR) was observed only at LC30. Although, the mean generation time (T) prolonged substantially at LC30. Additionally, expression of the CHS1 gene was significantly increased in F0 adults. Significant increase in the relative abundance of CHS1 mRNA transcript was also observed at the juvenile and adult stages of F1 generation following exposure to LC15 and LC30. Therefore, our results show that buprofezin could affect the biological traits by diminishing the chitin contents owing to the inhibition of chitin synthase activity in the succeeding generation of melon aphid.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31444364 PMCID: PMC6707215 DOI: 10.1038/s41598-019-48199-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Toxicity of buprofezin against A. gossypii after 48 and 72 h exposure. aStandard error; bConfidence limits; cChi-square values and degrees of freedom.
| Treatments | Slope ± SEa | LC15 mg L−1 (95% CLb) | LC30 mg L−1 (95% CLb) | LC50 mg L−1 (95% CLb) | χ2 (df)c | |
|---|---|---|---|---|---|---|
| Buprofezin (48 h) | 1.251 ± 0.165 | 1.125 (0.748 to 1.504) | 2.888 (2.231 to 3.804) | 7.586 (5.493 to 12.232) | 3.358 (16) | 0.999 |
| Buprofezin (72 h) | 1.627 ± 0.149 | 0.435 (0.302 to 0.571) | 0.898 (0.702 to 1.098) | 1.886 (1.570 to 2.274) | 11.113 (16) | 0.802 |
Mean ( ± SE) developmental times (d) of various life stages of F1 generation A. gossypii produced from parents (F0) and longevity (d) and fecundity (d) of F0 generation treated with LC15 and LC30 concentrations of buprofezin for 72 h compared to the untreated control.
| Treatments | 1st instar | 2nd instar | 3rd instar | 4th instar | Pre-adult | Adult Longevity F1 | Adult Fecundity F1 | Adult Longevity F0 | Adult Fecundity F0 |
|---|---|---|---|---|---|---|---|---|---|
| Control | 1.85 ± 0.07b | 1.48 ± 0.07b | 1.32 ± 0.06b | 1.03 ± 0.02c | 5.68 ± 0.06c | 25.38 ± 0.68a | 35.17 ± 0.23a | 21.16 ± 0.61a | 28.86 ± 0.82a |
| LC15 | 1.97 ± 0.05b | 1.62 ± 0.06b | 1.47 ± 0.07b | 1.28 ± 0.05b | 6.33 ± 0.07b | 18.40 ± 0.48b | 28.30 ± 0.81b | 14.03 ± 0.61b | 18.03 ± 0.84b |
| LC30 | 2.17 ± 0.04a | 1.98 ± 0.06a | 1.88 ± 0.07a | 1.82 ± 0.07a | 7.85 ± 0.05a | 10.83 ± 0.55c | 12.27 ± 0.25c | 8.30 ± 0.67c | 9.01 ± 0.66c |
Different letters within the same column represent significant differences at P < 0.05 level (one-way ANOVA followed by Tukey HSD tests).
Transgenerational effects of buprofezin on population parameters of the F1 generation of A. gossypii whose parents (F0 generation) were treated with LC15 and LC30 concentrations compared to untreated control. r: intrinsic rate of increase (d−1), λ: finite rate of increase (d−1), R0: net reproductive rate (offspring/individual), T: mean generation time (d), GRR: gross reproductive rate were calculated using 100,000 bootstraps resampling.
| Parameters | Control (Mean ± SE) | LC15 (Mean ± SE) | Control (Mean ± SE) | LC30 (Mean ± SE) | ||
|---|---|---|---|---|---|---|
| 0.302 ± 0.0054a | 0.275 ± 0.0050b | 0.0002 | 0.302 ± 5.413a | 0.196 ± 0.0030b | <0.001 | |
| 1.353 ± 0.0073a | 1.317 ± 0.0066b | 0.0002 | 1.353 ± 7.325a | 1.217 ± 0.0037b | <0.001 | |
| 35.166 ± 0.302a | 28.236 ± 0.820b | <0.001 | 35.166 ± 0.302a | 12.266 ± 0.256b | <0.001 | |
| 11.771 ± 0.217a | 12.125 ± 0.212a | 0.243 | 11.771 ± 0.217b | 12.741 ± 0.223a | 0.0019 | |
| 42.412 ± 0.923a | 40.529 ± 1.359a | 0.221 | 42.412 ± 0.923a | 21.137 ± 0.983b | <0.001 |
Different letters within the same row show significant differences between control and buprofezin concentration groups (at the P < 0.05 level, paired bootstrap test using TWOSEX MS chart program).
Figure 1Age-stage specific survival rate (s) of A. gossypii of the F1 generation produced from parents (F0) under control condition (A), treated with LC15 (B), and treated with LC30 (C) of buprofezin.
Figure 2Age-specific survival rate (l), age-specific fecundity (m) and age-specific maternity (lm) of control (A) and A. gossypii individuals of F1 generation descending from F0 individuals exposed to the LC15 (B) and LC30 (C) concentrations of buprofezin.
Figure 3Age-stage reproductive value (v) of A. gossypii individuals of the F1 generation produced from parents (F0) under control conditions (A), treated with LC15 (B) and treated with LC30 (C) concentration of buprofezin.
Figure 4Age-stage specific survival rate (e) of A. gossypii descending from parents (F0) under control condition (A), treated with LC15 (B), and treated with LC30 (C) concentrations of buprofezin.
Figure 5Relative expression levels of the chitin synthase 1 gene (CHS1) in F0 adults and in all developmental stages along with newly emerged adult melon aphid of F1 generation descending from the parent (F0) exposed to the LC15 and LC30 concentrations of buprofezin for 72 h. The relative expression level is expressed as the mean (±SE) with the control as the calibrator. Different letters above the error bars indicate significant differences at P < 0.05 level (one-way ANOVA followed by Tukey HSD tests).
Primer sequences for chitin synthase 1 (CHS1) and internal control genes used to determine the expression profile in A. gossypii following exposure to buprofezin.
| Primer name | Sequence (5′-3′) | Application |
|---|---|---|
| ATTGCGTCACGATGATCCTT | qRT-PCR | |
| TGGTCGCTAGACGTTCACAC | qRT-PCR | |
| EF1α-F | GAAGCCTGGTATGGTTGTCGT | qRT-PCR |
| EF1α-R | GGGTGGGTTGTTCTTTGTG | qRT-PCR |
| β-Actin-F | GGGAGTCATGGTTGGTATGG | qRT-PCR |
| β-Actin-R | TCCATATCGTCCCAGTTGGT | qRT-PCR |
| GAPDH-F | AACAGTTTTTTGAGTGGCGGT | qRT-PCR |
| GAPDH-R | TGGTGTCAACTTGGATGCGTA | qRT-PCR |